Showing results (2781-2790 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|October 4, 2005
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesJohn B Buse, Cindy J Rubin, Robert Frederich, et al.Clinical Therapeutics|October 4, 2005
A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemiaAlexandria Garavaglia Wilson, Scott T Micek, David J RitchieClinical Therapeutics|October 4, 2005
Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus reportMyron ZittClinical Therapeutics|October 4, 2005
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumoniaAndrew F Shorr, Neringa Zadeikis, Jim X Xiang, et al.Clinical Therapeutics|October 4, 2005
Acute interstitial nephritis associated with moxifloxacin useMichael Argirov, Gesa Ricken, Daniel Zecher, et al.Clinical Therapeutics|February 14, 2007
Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitisAdelaide A HebertClinical Therapeutics|February 14, 2007
A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's diseaseRoja Rahimi, Shekoufeh Nikfar, Ali Rezaie, et al.Clinical Therapeutics|February 14, 2007
Ranolazine for the management of coronary artery diseaseJudy W M ChengClinical Therapeutics|February 14, 2007
Lubiprostone: chloride channel activator for chronic constipationAnastasia Rivkin, Larisa ChaganClinical Therapeutics|February 14, 2007
Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled studyRudolf Likar, Martina Wittels, Mario Molnar, et al.Pageof 680